Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Muscarinic Antagonists"" wg kryterium: Temat


Tytuł:
Novel long-acting antagonists of muscarinic ACh receptors.
Autorzy:
Randáková A; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Rudajev V; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Doležal V; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Boulos J; Department of Physical Sciences, Barry University, Miami Shores, FL, USA.
Jakubík J; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2018 May; Vol. 175 (10), pp. 1731-1743. Date of Electronic Publication: 2018 Apr 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Muscarinic Antagonists/*pharmacology
Pyridines/*pharmacology
Receptors, Muscarinic/*metabolism
Animals ; CHO Cells ; Carbachol/chemistry ; Carbachol/pharmacology ; Cells, Cultured ; Cricetulus ; Dose-Response Relationship, Drug ; Molecular Structure ; Muscarinic Antagonists/chemical synthesis ; Muscarinic Antagonists/chemistry ; Pyridines/chemical synthesis ; Pyridines/chemistry ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release.
Autorzy:
Thomson K; Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, Canberra, Australian Capital Territory, Australia.
Kelly T; National Centre for Forensic Studies, Faculty of Science and Technology, University of Canberra, Canberra, Australian Capital Territory, Australia.
Karouta C; Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, Canberra, Australian Capital Territory, Australia.
Morgan I; Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
Ashby R; Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, Canberra, Australian Capital Territory, Australia.; Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2021 Nov; Vol. 178 (22), pp. 4501-4517. Date of Electronic Publication: 2021 Oct 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atropine*/pharmacology
Myopia*/drug therapy
Animals ; Chickens ; Dopamine ; Humans ; Muscarinic Antagonists/pharmacology ; Retina
Czasopismo naukowe
Tytuł:
Novel M 2 -selective, G i -biased agonists of muscarinic acetylcholine receptors.
Autorzy:
Randáková A; Department of Neurochemistry, Institute of Physiology CAS, Prague, Czech Republic.
Nelic D; Department of Neurochemistry, Institute of Physiology CAS, Prague, Czech Republic.
Ungerová D; Department of Neurochemistry, Institute of Physiology CAS, Prague, Czech Republic.
Nwokoye P; Department of Physical Sciences, Barry University, Miami Shores, Florida.
Su Q; Department of Physical Sciences, Barry University, Miami Shores, Florida.
Doležal V; Department of Neurochemistry, Institute of Physiology CAS, Prague, Czech Republic.
El-Fakahany EE; Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
Boulos J; Department of Physical Sciences, Barry University, Miami Shores, Florida.
Jakubík J; Department of Neurochemistry, Institute of Physiology CAS, Prague, Czech Republic.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2020 May; Vol. 177 (9), pp. 2073-2089. Date of Electronic Publication: 2020 Feb 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Muscarinic Agonists*/pharmacology
Receptors, Muscarinic*
Animals ; CHO Cells ; Cricetinae ; Cricetulus ; Muscarinic Antagonists/pharmacology ; Rats ; Receptor, Muscarinic M2 ; Signal Transduction
Czasopismo naukowe
Tytuł:
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.
Autorzy:
Rogliani P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Matera MG; Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Facciolo F; Thoracic Surgery Unit, Regina Elena National Cancer Institute, Rome, Italy.
Page C; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UK.
Cazzola M; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Calzetta L; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2020 Mar; Vol. 177 (5), pp. 1150-1163. Date of Electronic Publication: 2020 Jan 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glycopyrrolate*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/drug therapy
Administration, Inhalation ; Adrenergic beta-2 Receptor Agonists ; Beclomethasone/pharmacology ; Beclomethasone/therapeutic use ; Bronchodilator Agents/pharmacology ; Drug Combinations ; Drug Therapy, Combination ; Formoterol Fumarate/therapeutic use ; Humans ; Muscarinic Antagonists/pharmacology ; Muscle, Smooth
Czasopismo naukowe
Tytuł:
Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.
Autorzy:
Moulton BC; Division Pulmonary and Critical Care Medicine, Oregon Health Sciences University, Portland, 97239, USA. />Fryer AD
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2011 May; Vol. 163 (1), pp. 44-52.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
Muscarinic Antagonists/*pharmacology
Muscarinic Antagonists/*therapeutic use
Animals ; Asthma/drug therapy ; Drug Discovery ; Humans ; Muscarinic Antagonists/adverse effects ; Pulmonary Disease, Chronic Obstructive/drug therapy
Czasopismo naukowe
Tytuł:
Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Autorzy:
Oki T; Department of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan.
Sato S
Miyata K
Yamada S
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2005 May; Vol. 145 (2), pp. 219-27.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Muscarinic Antagonists/*pharmacology
Quinuclidines/*pharmacology
Receptors, Muscarinic/*metabolism
Salivation/*drug effects
Tetrahydroisoquinolines/*pharmacology
Administration, Oral ; Animals ; Depression, Chemical ; In Vitro Techniques ; Male ; Mandelic Acids/blood ; Mandelic Acids/pharmacology ; Mice ; Muscarinic Antagonists/blood ; Muscarinic Antagonists/metabolism ; Quinuclidines/blood ; Quinuclidines/metabolism ; Radioligand Assay ; Salivary Glands/metabolism ; Solifenacin Succinate ; Tetrahydroisoquinolines/blood ; Tetrahydroisoquinolines/metabolism ; Urinary Bladder/metabolism
Czasopismo naukowe
Tytuł:
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
Autorzy:
Abrams P; Bristol Urological Institute, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB. paul_ />Andersson KE
Buccafusco JJ
Chapple C
de Groat WC
Fryer AD
Kay G
Laties A
Nathanson NM
Pasricha PJ
Wein AJ
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2006 Jul; Vol. 148 (5), pp. 565-78. Date of Electronic Publication: 2006 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Muscarinic Antagonists/*therapeutic use
Receptors, Muscarinic/*metabolism
Receptors, Muscarinic/*physiology
Urinary Bladder, Overactive/*drug therapy
Animals ; Dose-Response Relationship, Drug ; Humans ; Models, Biological ; Muscarinic Antagonists/pharmacokinetics ; Receptor, Muscarinic M3/antagonists & inhibitors ; Receptor, Muscarinic M3/metabolism ; Receptor, Muscarinic M3/physiology ; Tissue Distribution
Czasopismo naukowe
Tytuł:
The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice.
Autorzy:
Malik M; Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, USA.
Rangel-Barajas C
Sumien N
Su C
Singh M
Chen Z
Huang RQ
Meunier J
Maurice T
Mach RH
Luedtke RR
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2015 May; Vol. 172 (10), pp. 2519-31. Date of Electronic Publication: 2015 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Acetanilides/*pharmacology
Acetanilides/*therapeutic use
Cognition Disorders/*chemically induced
Cognition Disorders/*drug therapy
Muscarinic Antagonists/*pharmacology
Piperidines/*pharmacology
Piperidines/*therapeutic use
Receptors, sigma/*agonists
Receptors, sigma/*metabolism
Animals ; Astrocytes/drug effects ; Astrocytes/metabolism ; Avoidance Learning/drug effects ; Brain-Derived Neurotrophic Factor/metabolism ; Ligands ; Male ; Maze Learning/drug effects ; Mice ; Rats ; Scopolamine/pharmacology ; Sigma-1 Receptor
Czasopismo naukowe
Tytuł:
Protons modulate perivascular axo-axonal neurotransmission in the rat mesenteric artery.
Autorzy:
Takatori S; Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, Matsuyama, Ehime, Japan; Department of Clinical Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Hirai K
Ozaki S
Tangsucharit P
Fukushima-Miyashita S
Goda M
Hashikawa-Hobara N
Ono N
Kawasaki H
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2014 Dec; Vol. 171 (24), pp. 5743-56.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Protons*
Adrenergic Neurons/*metabolism
Axons/*metabolism
Calcitonin Gene-Related Peptide/*metabolism
Mesenteric Arteries/*innervation
Synaptic Transmission/*physiology
Vasoconstriction/*physiology
Vasodilation/*physiology
Acetylcholine/pharmacology ; Adrenergic Neurons/drug effects ; Animals ; Atropine/pharmacology ; Axons/drug effects ; Calcitonin Gene-Related Peptide/drug effects ; Capsaicin/analogs & derivatives ; Capsaicin/pharmacology ; Cholinergic Agonists/pharmacology ; Guanethidine/pharmacology ; Hydrogen-Ion Concentration/drug effects ; Mecamylamine/pharmacology ; Muscarinic Antagonists/pharmacology ; Nicotinic Antagonists/pharmacology ; Rats ; Ruthenium Red/pharmacology ; Sympatholytics/pharmacology ; Synaptic Transmission/drug effects ; Vasoconstriction/drug effects ; Vasodilation/drug effects
Czasopismo naukowe
Tytuł:
Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.
Autorzy:
Figueiredo, TH
Aroniadou-Anderjaska, V
Qashu, F
Apland, JP
Pidoplichko, V
Stevens, D
Ferrara, TM
Braga, MFM
Figueiredo, T H (AUTHOR)
Apland, J P (AUTHOR)
Ferrara, T M (AUTHOR)
Braga, M F M (AUTHOR)
Pokaż więcej
Źródło:
British Journal of Pharmacology. Nov2011, Vol. 164 Issue 5, p1495-1505. 11p.
Czasopismo naukowe
Tytuł:
Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat.
Autorzy:
Andersson MC; Department of Pharmacology, the Sahlgrenska Academy at Göteborg University, Gothenburg, Sweden.
Tobin G
Giglio D
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2008 Apr; Vol. 153 (7), pp. 1438-44. Date of Electronic Publication: 2008 Feb 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cystitis/*physiopathology
Nitric Oxide/*metabolism
Urinary Bladder/*physiopathology
Animals ; Cyclophosphamide ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Male ; Methacholine Chloride/pharmacology ; Mucous Membrane/metabolism ; Mucous Membrane/physiopathology ; Muscarinic Agonists/administration & dosage ; Muscarinic Agonists/pharmacology ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptor, Muscarinic M3/metabolism ; Receptor, Muscarinic M5/metabolism ; Urinary Bladder/metabolism ; Urothelium/metabolism ; Urothelium/physiopathology
Czasopismo naukowe
Tytuł:
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor.
Autorzy:
Dowling MR; Novartis Institutes for Biomedical Research, Wimblehurst Road, Horsham, West Sussex RH12 5AB. />Charlton SJ
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2006 Aug; Vol. 148 (7), pp. 927-37. Date of Electronic Publication: 2006 Jul 10.
Typ publikacji:
Journal Article
MeSH Terms:
Muscarinic Antagonists/*metabolism
Muscarinic Antagonists/*pharmacology
Receptor, Muscarinic M3/*drug effects
Receptor, Muscarinic M3/*metabolism
Algorithms ; Animals ; Atropine/pharmacology ; Binding, Competitive/drug effects ; CHO Cells ; Cell Membrane/drug effects ; Cell Membrane/metabolism ; Cricetinae ; Indicators and Reagents ; Kinetics ; Ligands ; N-Methylscopolamine/metabolism ; N-Methylscopolamine/pharmacology ; Radioligand Assay ; Scopolamine Derivatives/pharmacology ; Tiotropium Bromide
Czasopismo naukowe
Tytuł:
Muscarinic receptors in the bladder: from basic research to therapeutics.
Autorzy:
Hegde SS; Department of Pharmacology, Theravance, Inc., South San Francisco, CA 94087, USA.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2006 Feb; Vol. 147 Suppl 2, pp. S80-7.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Receptors, Muscarinic/*metabolism
Urinary Bladder/*metabolism
Urinary Bladder, Overactive/*metabolism
Animals ; Humans ; Mice ; Mice, Knockout ; Muscarinic Antagonists/pharmacokinetics ; Muscarinic Antagonists/pharmacology ; Muscarinic Antagonists/therapeutic use ; Patient Compliance ; Receptor, Muscarinic M2/metabolism ; Receptor, Muscarinic M3/metabolism ; Receptors, Muscarinic/drug effects ; Receptors, Muscarinic/genetics ; Treatment Outcome ; Urinary Bladder/drug effects ; Urinary Bladder, Overactive/drug therapy
Czasopismo naukowe
Tytuł:
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Autorzy:
Sagi Y; Eve Topf and U.S.A. National Parkinson Foundation, Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Technion-Rappaport Faculty of Medicine, Haifa, Israel.
Driguès N
Youdim MB
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2005 Oct; Vol. 146 (4), pp. 553-60.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Basal Ganglia/*drug effects
Behavior, Animal/*drug effects
Cholinesterase Inhibitors/*pharmacology
Hippocampus/*drug effects
Hyperkinesis/*prevention & control
Indans/*pharmacology
Monoamine Oxidase Inhibitors/*pharmacology
Motor Activity/*drug effects
Animals ; Basal Ganglia/enzymology ; Carbamates/administration & dosage ; Carbamates/pharmacology ; Cholinesterase Inhibitors/administration & dosage ; Dopamine/metabolism ; Hippocampus/enzymology ; Hyperkinesis/chemically induced ; Indans/administration & dosage ; Levodopa/administration & dosage ; Levodopa/adverse effects ; Lewy Body Disease/drug therapy ; Male ; Monoamine Oxidase Inhibitors/administration & dosage ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/pharmacology ; Norepinephrine/metabolism ; Phenylcarbamates/administration & dosage ; Phenylcarbamates/pharmacology ; Rats ; Rats, Sprague-Dawley ; Rivastigmine ; Scopolamine/administration & dosage ; Scopolamine/pharmacology ; Serotonin/metabolism ; Time Factors ; Tranylcypromine/administration & dosage ; Tranylcypromine/adverse effects ; Tranylcypromine/pharmacology ; Tryptophan/administration & dosage ; Tryptophan/adverse effects
Czasopismo naukowe
Tytuł:
Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy.
Autorzy:
Jakubík J; Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic. />Janíčková H
El-Fakahany EE
Doležal V
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2011 Mar; Vol. 162 (5), pp. 1029-44.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Guanosine Diphosphate/*metabolism
Muscarinic Agonists/*metabolism
Allosteric Regulation ; Animals ; CHO Cells ; Cricetinae ; Cricetulus ; GTP-Binding Proteins/classification ; GTP-Binding Proteins/metabolism ; Guanosine 5'-O-(3-Thiotriphosphate)/metabolism ; Humans ; Kinetics ; Muscarinic Antagonists/metabolism ; N-Methylscopolamine/metabolism ; Protein Binding ; Radioligand Assay ; Receptor, Muscarinic M2/genetics ; Receptor, Muscarinic M2/metabolism ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Transfection
Czasopismo naukowe
Tytuł:
AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.
Autorzy:
Sinha S; Department of Pharmacology, Ranbaxy Laboratories Ltd., Gurgaon, Haryana, India.
Gupta S
Malhotra S
Krishna NS
Meru AV
Babu V
Bansal V
Garg M
Kumar N
Chugh A
Ray A
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2010 Jul; Vol. 160 (5), pp. 1119-27.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Bridged Bicyclo Compounds, Heterocyclic/*pharmacology
Muscarinic Antagonists/*pharmacology
Salivary Glands/*drug effects
Urinary Bladder, Overactive/*drug therapy
Animals ; Brain/metabolism ; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage ; CHO Cells ; Carbachol/antagonists & inhibitors ; Cell Line, Transformed ; Cricetinae ; Cricetulus ; Dose-Response Relationship, Drug ; Female ; Humans ; Injections, Intravenous ; Male ; Mice ; Rabbits ; Rats
Czasopismo naukowe
Tytuł:
Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.
Autorzy:
Kubista H; Centre of Biomolecular Medicine and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria.
Kosenburger K
Mahlknecht P
Drobny H
Boehm S
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2009 Apr; Vol. 156 (8), pp. 1342-52. Date of Electronic Publication: 2009 Mar 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neural Inhibition*/drug effects
Synaptic Transmission*/drug effects
Adrenergic Fibers/*metabolism
Norepinephrine/*metabolism
Presynaptic Terminals/*metabolism
Receptor, Muscarinic M1/*metabolism
Receptors, Presynaptic/*metabolism
Superior Cervical Ganglion/*metabolism
Acetylcholine/metabolism ; Action Potentials ; Adrenergic Fibers/drug effects ; Animals ; Animals, Newborn ; Calcium Channel Blockers/pharmacology ; Calcium Channels/metabolism ; Calcium Signaling ; Carbamates/pharmacology ; Cells, Cultured ; Diamines/pharmacology ; Dose-Response Relationship, Drug ; Electric Stimulation ; KCNQ Potassium Channels/metabolism ; Muscarinic Agonists/pharmacology ; Muscarinic Antagonists/pharmacology ; Oxotremorine/pharmacology ; Pertussis Toxin/pharmacology ; Phenylenediamines/pharmacology ; Pirenzepine/pharmacology ; Presynaptic Terminals/drug effects ; Rats ; Rats, Sprague-Dawley ; Receptor, Muscarinic M1/drug effects ; Receptors, Presynaptic/drug effects ; Superior Cervical Ganglion/cytology ; Superior Cervical Ganglion/drug effects ; Time Factors ; Type C Phospholipases/metabolism ; omega-Conotoxin GVIA/pharmacology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies